Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Medrxiv : the Preprint Server for Health Sciences|September 10, 2024
Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression ProfilesItzel Valencia, Pier Vitale Nuzzo, Edoardo Francini, et al.Clinical Lung Cancer|June 15, 2015
Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution ExperienceRoberto Petrioli, Giandomenico Roviello, Letizia Laera, et al.Cancer Chemotherapy and Pharmacology|April 13, 2007
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatinRoberto Petrioli, Alessandra Pascucci, Edoardo Francini, et al.Clinical Colorectal Cancer|August 30, 2018
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal CancerRoberto Petrioli, Edoardo Francini, Sara Cherri, et al.Cancer Investigation|January 13, 2012
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumabRoberto Petrioli, Antonella Licchetta, Giandomenico Roviello, et al.BJU International|May 31, 2007
Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxelRoberto Petrioli, Alessandra Pascucci, Edoardo Francini, et al.Cancer Chemotherapy and Pharmacology|March 7, 2015
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experienceRoberto Petrioli, Edoardo Francini, Franco Roviello, et al.Journal of Geriatric Oncology|August 1, 2015
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance statusRoberto Petrioli, Edoardo Francini, Franco Roviello, et al.Medical Oncology (Northwood, London, England)|March 23, 2015
Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II studyRoberto Petrioli, Edoardo Francini, Anna Ida Fiaschi, et al.European Urology|September 21, 2024
Intensification Approaches and Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer: A Systematic ReviewEdoardo Francini, Neeraj Agarwal, Elena Castro, et al.Pageof 8